A PYMNTS Company

Denmark’s Novozymes To Buy US Microbiome Labs

By  |  December 20, 2020

Novozymes will acquire US based Microbiome Labs in a $125 million deal, it said on Friday, its second takeover this year of a company specialising in probiotics and gut health.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    “Over the span of just a few years, the team at Microbiome Labs has built a solid market position and become a key opinion leader on the microbiome in the consumer health industry,” Chief Executive Ester Baiget said in a statement.

    The deal, financed through cash and bank facilities, is expected to close in the first half of January next year, and is not subject to antitrust filings.

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.